Inactive Instrument

Highlights Kuros Biosciences AG Swiss Exchange

Equities

CH0011025217

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

04-24	Kuros Biosciences Posts Higher Q1 Product Sales	MT
04-17	Kuros Biosciences AG Approves Board of Director and Committee Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kuros Biosciences' FY23 Attributable Loss Shrinks; Revenue Up	03-13	MT
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	03-11	CI
Kuros Biosciences Receives US FDA 510K Clearance for Magnetos Granules for Interbody Use and Regulatory Clearance of Magnetos Granules and Magnetos Putty in New Zealand	01-31	CI
Kuros Biosciences Announces Three Advancements Related to its MagnetOs Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA	01-04	CI
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA	12-27	CI
Kuros Biosciences Receives FDA Clearance for Use of Magnetos in Interbody Spinal Cages	11-28	CI
Kuros Biosciences Books Greater Loss; Revenue Grows	09/08/23	MT
Kuros Biosciences AG Reports Earnings Results for the Half Year Ended June 30, 2023	29/07/23	CI
Kuros Biosciences Net Loss Widens in FY22	15/03/23	MT
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2022	15/03/23	CI
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2022	15/03/23	CI
Kuros Biosciences’ MagnetOs Bone Graft Successfully Achieves Three Key Milestones	23/08/22	CI
Kuros Biosciences Widens Net Loss in H1; Revenue Jumps	09/08/22	MT
Kuros Biosciences AG Reports Earnings Results for the Half Year Ended June 30, 2022	09/08/22	CI
Regeneron Completes Checkmate Pharmaceuticals Deal, Triggers $5 Million Milestone Payment to Kuros Biosciences	02/06/22	MT
Kuros To Receive $5 Million Milestone Payment from Regeneron's Acquisition Of Checkmate	02/06/22	MT
Switzerland's Kuros Biosciences Launches Bone Graft MagnetOs In US	18/05/22	MT
Kuros Biosciences’S Magnetos Flex Matrix Receives Clearance by U.S. Food and Drug Administration for Spinal Indications	21/04/22	CI
Kuros Biosciences' Net Loss Shrinks in FY21 as Revenue Soars	16/03/22	MT
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2021	16/03/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kuros Biosciences AG Swiss Exchange

Equities

CH0011025217

Highlights

Filters